PDF(Pubmed)
Abstract：
BACKGROUND: Prenatal and postnatal depression (PND) is associated with adverse outcomes for mother, fetus, and child. The aim of study was to examine the prevalence and risk factors of prenatal and postnatal depressive symptoms.
METHODS: This was a cross-sectional and hospital-based survey of 2305 pregnant women and post-partum women (18-48 years) that was registered in the Babol Pregnancy Mental Health Registry (BPMHR) database from June 2020 to March 2021. Two questionnaires, including demographics and depression, were analyzed in this study. Also, the Edinburg Postnatal Depression Scale (EPDS) was used to assess the depressive symptoms. Independent t test and the analysis of variance were used to compare the means. Multiple logistic regressions were used to determine risk factors for depressive symptoms.
RESULTS: According to the EPDS scale, the prevalence of depressive symptoms was 19.8% in the pregnant woman group in comparison with the postpartum period (11.6%). Risk factors for antenatal depressive symptoms were parity (women with parity ≥ 4 vs. 1 parity, ß=1.808, P=0.020), two groups of gestational age (gestational age ≤12 weeks vs. 28 weeks, ß=1.562 P=0.030) as well as (gestational age 21-27 weeks vs. 28 weeks (ß=1.586, P=0.033), and high-risk pregnancy (high-risk vs. low-risk pregnancy, ß=1.457, P=0.003). For postnatal depressive symptoms, none of the factors were a significant risk.
CONCLUSIONS: Prenatal and postnatal depressive symptoms should be screened, particularly for women in the first and second trimesters, with high parity, and those with a high-risk pregnancy, as recommended by the present study.
METHODS: This was a cross-sectional and hospital-based survey of 2305 pregnant women and post-partum women (18-48 years) that was registered in the Babol Pregnancy Mental Health Registry (BPMHR) database from June 2020 to March 2021. Two questionnaires, including demographics and depression, were analyzed in this study. Also, the Edinburg Postnatal Depression Scale (EPDS) was used to assess the depressive symptoms. Independent t test and the analysis of variance were used to compare the means. Multiple logistic regressions were used to determine risk factors for depressive symptoms.
RESULTS: According to the EPDS scale, the prevalence of depressive symptoms was 19.8% in the pregnant woman group in comparison with the postpartum period (11.6%). Risk factors for antenatal depressive symptoms were parity (women with parity ≥ 4 vs. 1 parity, ß=1.808, P=0.020), two groups of gestational age (gestational age ≤12 weeks vs. 28 weeks, ß=1.562 P=0.030) as well as (gestational age 21-27 weeks vs. 28 weeks (ß=1.586, P=0.033), and high-risk pregnancy (high-risk vs. low-risk pregnancy, ß=1.457, P=0.003). For postnatal depressive symptoms, none of the factors were a significant risk.
CONCLUSIONS: Prenatal and postnatal depressive symptoms should be screened, particularly for women in the first and second trimesters, with high parity, and those with a high-risk pregnancy, as recommended by the present study.
摘要：
背景：产前和产后抑郁症（PND）与母亲的不良结局有关，胎儿,和孩子。研究的目的是检查产前和产后抑郁症状的患病率和危险因素。
方法：这是一项针对2305名孕妇和产后妇女（18-48岁）的横断面和基于医院的调查，该调查于2020年6月至2021年3月在巴博尔妊娠心理健康登记（BPMHR）数据库中注册。两份问卷，包括人口统计学和抑郁症，在这项研究中进行了分析。此外，采用Edinburg产后抑郁量表(EPDS)评估抑郁症状.采用独立t检验和方差分析比较均数。使用多重逻辑回归来确定抑郁症状的危险因素。
结果：根据EPDS量表，与产后期间相比，孕妇组抑郁症状的患病率为19.8％（11.6％）。产前抑郁症状的危险因素为胎次（胎次≥4的女性与1奇偶校验，β=1.808，P=0.020），两组胎龄(胎龄≤12周vs.28周,β=1.562P=0.030）以及（胎龄21-27周与28周（β=1.586，P=0.033），和高风险怀孕(高风险与低风险怀孕，β=1.457，P=0.003）。对于产后抑郁症状，这些因素均无显著风险.
结论：应筛查产前和产后抑郁症状，特别是对于妇女在第一和第二三个月，具有高奇偶校验，那些有高风险怀孕的人，根据本研究的建议。
方法：这是一项针对2305名孕妇和产后妇女（18-48岁）的横断面和基于医院的调查，该调查于2020年6月至2021年3月在巴博尔妊娠心理健康登记（BPMHR）数据库中注册。两份问卷，包括人口统计学和抑郁症，在这项研究中进行了分析。此外，采用Edinburg产后抑郁量表(EPDS)评估抑郁症状.采用独立t检验和方差分析比较均数。使用多重逻辑回归来确定抑郁症状的危险因素。
结果：根据EPDS量表，与产后期间相比，孕妇组抑郁症状的患病率为19.8％（11.6％）。产前抑郁症状的危险因素为胎次（胎次≥4的女性与1奇偶校验，β=1.808，P=0.020），两组胎龄(胎龄≤12周vs.28周,β=1.562P=0.030）以及（胎龄21-27周与28周（β=1.586，P=0.033），和高风险怀孕(高风险与低风险怀孕，β=1.457，P=0.003）。对于产后抑郁症状，这些因素均无显著风险.
结论：应筛查产前和产后抑郁症状，特别是对于妇女在第一和第二三个月，具有高奇偶校验，那些有高风险怀孕的人，根据本研究的建议。
